- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharmaceuticals
Actavis plc+ Add to Watchlist
ACT:US213.1800 USD 0.7700 0.36%
As of 20:04:05 ET on 03/07/2014.
Company Profile for Actavis plc (ACT)
Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.
Key Executives for Actavis plc (ACT)
|Paul M BisaroChairman/CEO||James D'AreccaChief Accounting Officer|
|Sigurdur Oli Olafsson "Siggi"President:Actavis Pharma||G Frederick Wilkinson "Fred"Pres:Global Research|
|Robert A Stewart "Bob"President:Global Operations||R Todd JoyceChief Financial Ofcr:Global|
|Charles M MayrChief Communications Ofcr:Global||David A BuchenChief Legal Ofcr:Global|
|Patrick J EaganChief Human Resources Ofcr:Global||Lisa M DefrancescoVP:Global Investor Relations|